Suppr超能文献

人转移性结肠癌中抗体定位的定量分析:单克隆抗体A33的I期研究

Quantitative analysis of antibody localization in human metastatic colon cancer: a phase I study of monoclonal antibody A33.

作者信息

Welt S, Divgi C R, Real F X, Yeh S D, Garin-Chesa P, Finstad C L, Sakamoto J, Cohen A, Sigurdson E R, Kemeny N

机构信息

Memorial Sloan-Kettering Cancer Center, New York, NY 10021.

出版信息

J Clin Oncol. 1990 Nov;8(11):1894-906. doi: 10.1200/JCO.1990.8.11.1894.

Abstract

A33 is a mouse immunoglobulin G2a (IgG2a) monoclonal antibody (mAb) that detects a heat-stable, protease- and neuraminidase-resistant epitope. The antigen is homogeneously expressed by virtually all colon cancers and in the colon mucosa but not other epithelial tissues. The biodistribution and imaging characteristics of iodine-131 (131I)-mAbA33 were studied in colorectal carcinoma patients with hepatic metastases. Antibody labeled with 2 to 5 mCi of 131I was administered intravenously (IV) 7 to 8 days before surgery at five dose levels, ranging from 0.2 mg to 50 mg, with three or more patients entered at each dose level. In addition, three patients received 2 mg 131I-mAbTA99 (an isotype-matched control mAb) together with 125I-mAbA33. Evaluation included whole-body imaging with a gamma camera, technetium-99 (99mTc)-human serum albumin blood pool scans, liver/spleen scans, abdominal computed tomographic (CT) scans, hepatic arteriograms, antibody pharmacokinetics, and assessment of antibody distribution in biopsied malignant and normal tissues. Selective mAbA33 localization to tumor tissue was demonstrated in 19 of 20 patients, and external imaging correlated with surgical inspection, pathologic examination, and tissue radioactivity. One week after antibody administration, tumor:liver ratios ranged from 6.9:1 to 100:1 and tumor:serum ratios from 4.1:1 to 25.2:1. 99mTc-albumin blood pool studies showed that liver metastases were hypovascular, emphasizing the selective localization of mAbA33 despite poor tumor-blood flow. Control mAbTA99 studies showed mAbA33 localization was antigen-specific; tumor:liver ratios were 2.3- to 45-fold higher for specific antibody. In metastatic lesions, radioisotope was localized primarily in the viable periphery; however, even the necrotic tumor core concentrated specific antibody. External imaging showed isotope visualization in some patients' large bowel; whether this represents specific antibody uptake or gastric iodine secretion is unclear.

摘要

A33是一种小鼠免疫球蛋白G2a(IgG2a)单克隆抗体(mAb),可检测一种热稳定、耐蛋白酶和神经氨酸酶的表位。该抗原在几乎所有结肠癌和结肠黏膜中均有均匀表达,但在其他上皮组织中不表达。对131I标记的mAbA33在伴有肝转移的结直肠癌患者中的生物分布和成像特征进行了研究。在手术前7至8天,以0.2mg至50mg的五个剂量水平静脉注射(IV)2至5mCi的131I标记抗体,每个剂量水平纳入三名或更多患者。此外,三名患者接受了2mg 131I-mAbTA99(一种同型匹配对照mAb)与125I-mAbA33联合使用。评估包括使用γ相机进行全身成像、99mTc-人血清白蛋白血池扫描、肝脏/脾脏扫描、腹部计算机断层扫描(CT)、肝动脉造影、抗体药代动力学以及对活检的恶性和正常组织中抗体分布的评估。在20例患者中有19例显示mAbA33选择性定位于肿瘤组织,并且外部成像与手术检查、病理检查和组织放射性相关。抗体给药一周后,肿瘤与肝脏的比值范围为6.9:1至100:1,肿瘤与血清的比值范围为4.1:1至25.2:1。99mTc-白蛋白血池研究表明肝转移灶血供不足,强调了尽管肿瘤血流不佳,但mAbA33仍具有选择性定位。对照mAbTA99研究表明mAbA33的定位具有抗原特异性;特异性抗体的肿瘤与肝脏比值高2.3至45倍。在转移病灶中,放射性同位素主要定位于存活的周边区域;然而,即使是坏死的肿瘤核心也会浓聚特异性抗体。外部成像显示一些患者的大肠中有同位素显影;这是代表特异性抗体摄取还是胃碘分泌尚不清楚。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验